DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR MS Speaks
       *****************************************************
   DIR (Abst.) Projected study investigating relationship between fin...
       0 replies
   DIR  Rebound syndrome in MS patients after stopping Gilenya
       4 replies
   DIR Randomized clinical trial: 2 fingolimod doses vs. Copaxone for...
       0 replies
   DIR FDA approves first generics of Gilenya
       0 replies
   DIR Fingolimod and liver injury research information (PubMed)
       0 replies
   DIR (Abst.) Gilenya vs. Tecfidera in MS...
       0 replies
   DIR (Abst.) PML after fingolimod treatment
       1 replies
   DIR Gilenya shows promise in pediatric MS
       1 replies
   DIR (Abst.) Switching from Tysabri to Gilenya within 6 weeks cuts ...
       0 replies
   DIR (AAN abst.) Alternate dosing of fingolimod for MS
       0 replies
       *****************************************************
   DIR Next Page